News & Publications for:

Mark Sands

Disease correction by combined neonatal intracranial AAV and systemic lentiviral gene therapy in Sanfilippo Syndrome type B mice

Posted on September 24, 2013

Heldermon CD, Qin EY, Ohlemiller KK, Herzog ED, Brown JR, Vogler C, Hou W, Orrock JL, Crawford BE, Sands MS; (2013) Gene Therapy, 20 (9), pp. 913-921. Read More

Posted in: Neurogenetics, Publications Faculty: ,

The sphingolipid psychosine inhibits fast axonal transport in krabbe disease by activation of GSK3β and deregulation of molecular motors

Posted on June 25, 2013

Cantuti Castelvetri, L., Givogri, M.I., Hebert, A., Smith, B., Song, Y., Kaminska, A., Lopez-Rosas, A., Morfini, G., Pigino, G., Sands, M., Brady, S.T., Bongarzone, E.R.;(2013) Journal of Neuroscience, 33 (24), pp. 10048-10056. Read More

Posted in: Publications Faculty:

Central Nervous System Pathology Progresses Independently of KC and CXCR2 in Globoid-Cell Leukodystrophy

Posted on June 17, 2013

Reddy, A.S., Patel, J.R., Vogler, C., Klein, R.S., Sands, M.S.; (2013) PLoS ONE, 8 (6), art. no. e64647 Read More

Posted in: Axon Injury & Repair, Publications Faculty: ,

Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells

Posted on July 6, 2012

Young MA, Larson DE, Sun CW, George DR, Ding L, Miller CA, Lin L, Pawlik KM, Chen K, Fan X, Schmidt H, Kalicki-Veizer J, Cook LL, Swift GW, Demeter RT, Wendl MC, Sands MS, Mardis ER, Wilson RK, Townes TM, Ley TJ (2012). Cell Stem Cell, 10(5):570-82 Read More

Posted in: Publications Faculty:

Mark Sands identifies combination treatment in mouse model of Batten disease

Posted on April 18, 2012

Gene therapy combined with bone marrow transplant synergizes to provide benefit in mouse model of this fatal childhood disease. Read More

Posted in: News Faculty: